Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

255.20
Delayed Data
As of May 29
 -0.83 / -0.33%
Today’s Change
128.50
Today|||52-Week Range
349.08
+63.59%
Year-to-Date

Today’s Trading

Previous close256.03
Today’s open257.00
Day’s range253.35 - 259.00
Volume246,871
Average volume (3 months)651,857
Market cap$6.1B
Dividend yield--
Data as of 4:14pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)-262.50%
Earnings growth (this year)+34.86%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+7.40%
P/E ratioNM
Price/Sales1,861.70
Price/Book23.67

Competitors

 Today’s
change
Today’s
% change
PBYIPuma Biotechnology I...-4.60-2.30%
IDXXIDEXX Laboratories I...-0.45-0.33%
TAROTaro Pharmaceutical ...-2.22-1.47%
SGENSeattle Genetics Inc-0.07-0.16%
Data as of 4:05pm ET, 05/29/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)-$2.00
Annual revenue (last year)$1.7M
Annual profit (last year)-$283.2M
Net profit margin-16,262.23%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer, Secretary &
Treasurer
Barbara Gayle Duncan
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers